The Liver Cancer Drug Pipeline Analysis explores the ongoing development of targeted and immunotherapeutic treatments aimed at combating liver cancer, particularly hepatocellular carcinoma (HCC), the most common type. With liver cancer ranking among the leading causes of cancer-related deaths globally, there is a significant focus on novel drug candidates including immune checkpoint i... https://www.expertmarketresearch.com/clinical-trials/liver-cancer-drug-pipeline-insight